Zobrazeno 1 - 10
of 31
pro vyhledávání: '"YOKO FUKASAWA"'
Autor:
Chikako Funasaka, Yoichi Naito, Shota Kusuhara, Takehiro Nakao, Yoko Fukasawa, Kanako Mamishin, Ayumi Komuro, Mashiro Okunaka, Chihiro Kondoh, Kenichi Harano, Takahiro Kogawa, Nobuaki Matsubara, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara
Publikováno v:
Breast, Vol 58, Iss , Pp 50-56 (2021)
Background: Visceral crisis in metastatic breast cancer (MBC) is defined as severe organ dysfunction requiring rapidly efficacious therapy. Although weekly paclitaxel plus bevacizumab (wPTX + BV) achieves a high response rate in human epidermal growt
Externí odkaz:
https://doaj.org/article/1ee0cb78f98046edb5ecc170618af845
Autor:
Shuji Ota, Yoshihide Fujigaki, Yoshifuru Tamura, Kenichiro Kojima, Ryosuke Ochiai, Terunobu Haruyama, Masashi Ishihara, Maika Natsume, Yoko Fukasawa, Takahiko Sakamoto, Shigeru Tanzawa, Ryo Usui, Takeshi Honda, Yasuko Ichikawa, Kiyotaka Watanabe, Nobuhiko Seki
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 53-58 (2019)
We encountered a case of primary lung cancer complicated with membranous nephropathy as primary nephrotic syndrome. Because treatment approaches vary greatly for primary and secondary nephrotic syndrome, a renal biopsy was performed for diagnosis. Mu
Externí odkaz:
https://doaj.org/article/4615de9c573545b4af13c879eee9ea36
Autor:
Nobuhiko Seki, Maika Natsume, Ryosuke Ochiai, Terunobu Haruyama, Masashi Ishihara, Yoko Fukasawa, Takahiko Sakamoto, Shigeru Tanzawa, Ryo Usui, Takeshi Honda, Shuji Ota, Yasuko Ichikawa, Kiyotaka Watanabe
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 91-97 (2019)
In lung cancer, several potential mechanisms of intrinsic and acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been explored, including mesenchymal-epithelial transition factor (MET) signaling path
Externí odkaz:
https://doaj.org/article/a61b5c25b787476fbe1244205dda983b
Autor:
Nobuhiko Seki, Ryosuke Ochiai, Terunobu Haruyama, Masashi Ishihara, Maika Natsume, Yoko Fukasawa, Takahiko Sakamoto, Shigeru Tanzawa, Ryo Usui, Takeshi Honda, Shuji Ota, Yasuko Ichikawa, Kiyotaka Watanabe
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 84-90 (2019)
Common dermatological side-effects associated with erlotinib, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), include pruritus and skin rash, which are mediated by substance P, leading to the occasional discontinuation of can
Externí odkaz:
https://doaj.org/article/40090f0423a64e93bdb813d6f7b3048b
Autor:
Shuji Ota, Takahiko Sakamoto, Ryosuke Ochiai, Terunobu Haruyama, Masashi Ishihara, Maika Natsume, Yoko Fukasawa, Shigeru Tanzawa, Ryo Usui, Takeshi Honda, Yasuko Ichikawa, Kiyotaka Watanabe, Yuko Sasajima, Atsushi Mizota, Nobuhiko Seki
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 47-52 (2019)
For sebaceous carcinoma (SC), a rare malignant tumor, no standard chemotherapy regimen for patients with distant metastasis has been studied. We experienced a case of eyelid SC with multiple lung metastases that responded to combination chemotherapy
Externí odkaz:
https://doaj.org/article/a5ba2122f7814fb9a5841893a0770889
Autor:
Shuji Ota, Terunobu Haruyama, Masashi Ishihara, Maika Natsume, Yoko Fukasawa, Takahiko Sakamoto, Shigeru Tanzawa, Ryo Usui, Takeshi Honda, Yasuko Ichikawa, Kiyotaka Watanabe, Yuko Sasajima, Nobuhiko Seki
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 1, Pp 11-16 (2018)
The patient was a 66-year-old woman. An induration of approximately 15 mm in size that accompanied redness was palpable in the umbilical fossa. She did not respond to 1-month antibiotic treatment provided by the previous physician. For this reason, a
Externí odkaz:
https://doaj.org/article/4b5aa4e7406c4ff49d1011efa73d7f3c
Autor:
Yoko Fukasawa, Takeshi Honda, Maika Natsume, Terunobu Haruyama, Masashi Ishihara, Takahiko Sakamoto, Ryo Usui, Shigeru Tanzawa, Shuji Ota, Yasuko Ichikawa, Kiyotaka Watanabe, Koji Saito, Nobuhiko Seki
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 1127-1130 (2017)
A 73-year-old man, followed for prostatic hyperplasia, developed submandibular gland cancer. Initially, because of the concurrent presence of elevated serum prostate-specific antigen (PSA) and multiple bone metastases, he was clinically determined as
Externí odkaz:
https://doaj.org/article/f02c76a521f04b0da2363bb47e4245de
Autor:
Takahiko Sakamoto, Shuji Ota, Terunobu Haruyama, Masashi Ishihara, Maika Natsume, Yoko Fukasawa, Shigeru Tanzawa, Ryo Usui, Takeshi Honda, Yasuko Ichikawa, Kiyotaka Watanabe, Nobuhiko Seki
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 1131-1137 (2017)
The patient was a 69-year-old male who had started experiencing acute-onset pain in both shoulder joints and edema of both hands and feet. His symptoms progressively worsened within 1 month. Laboratory data indicated elevated CRP and erythrocyte sedi
Externí odkaz:
https://doaj.org/article/16cef98e49904190b20f36d467924ddc
Autor:
Maika Natsume, Takeshi Honda, Terunobu Haruyama, Masashi Ishihara, Yoko Fukasawa, Takahiko Sakamoto, Shigeru Tanzawa, Ryo Usui, Shuji Ota, Yasuko Ichikawa, Kiyotaka Watanabe, Nobuhiko Seki
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 1065-1069 (2017)
A 40-year-old man with a diagnosis of lung adenocarcinoma (cT4N3M1c, stage IVB) experienced worsening of lymphangitic carcinomatosis in the right lung and right pleural effusion after receiving 1 cycle of first-line chemotherapy consisting of cisplat
Externí odkaz:
https://doaj.org/article/247788090b744adbacd84ac26a5aefe1
Autor:
Yoko Fukasawa, Kazuya Sasaki, Maika Natsume, Makoto Nakashima, Shuji Ota, Kiyotaka Watanabe, Yoshihisa Takahashi, Fukuo Kondo, Ken Kozuma, Nobuhiko Seki
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 809-812 (2017)
We report a 69-year-old female patient with advanced lung cancer who developed myocarditis concomitant with myasthenia gravis (MG), also known as “Herzmyasthenie,” after 3 cycles of nivolumab administration. Her initial symptoms were general mala
Externí odkaz:
https://doaj.org/article/eb8df471756143cead112c05ad08e785